Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Pharma channel feed
FDA to take another look at Akebia's rejected kidney drug
3 years ago
FDA+
Big Pharma has harsh words for UK's ballooning voluntary reimbursement agreement
3 years ago
BIO renews video series with new pharma partners, including Pfizer, Eli Lilly and Merck
3 years ago
Marketing
Myeloid Therapeutics goes down under for new manufacturing site, with $66M local investment
3 years ago
Cell/Gene Tx
Manufacturing
MarketingRx roundup: CVS amps Moderna’s CMV vaccine trial; Another star in Pfizer’s Covid vaccination sky
3 years ago
Marketing
The new pharma celebrities: Famous patients with social influence are ‘just getting started’
3 years ago
Marketing
FDA clears Travere’s rare kidney disease drug, will come with REMS program
3 years ago
FDA+
FDA approves Apellis' retinal disease drug as competitor expects August decision
3 years ago
FDA+
Daiichi Sankyo gets US patent office to restart review of Seagen patent
3 years ago
Law
Oxford Properties Group purchases Resilience manufacturing site for $125M
3 years ago
Deals
Manufacturing
French court overturns €444M antitrust fine against Roche, Novartis
3 years ago
Law
FDA gives the OK to Chiesi for treatment of ultra-rare enzyme deficiency disease
3 years ago
FDA+
Updated: Pfizer drops half of participants from Lyme trial after saying research contractor broke rules
3 years ago
R&D
Biogen chairman Papadopoulos, who saw company through highs and lows, to retire
3 years ago
People
UK could allow reciprocal drug approvals with US FDA as soon as 2024
3 years ago
FDA+
Bristol Myers, Pfizer team up with basketball legend Kareem Abdul-Jabbar on stroke risk campaign
3 years ago
Marketing
Senate begins quest to demystify PBMs' practices as it mulls legislation
3 years ago
Klick Health adds commercial venture group for early-stage biotechs and ‘modern’ health companies
3 years ago
Marketing
Rise in consumer convenience disrupts traditional pharma-to-physician marketing, ZS research finds
3 years ago
Marketing
Drug prices 'not justified' by pharma R&D spending, new study says
3 years ago
R&D
Over-the-counter Narcan gets unanimous thumbs-up from FDA advisors
3 years ago
FDA+
Spain's Grifols to dismiss more than 2,000 US employees in $427M cost savings bid
3 years ago
People
Biogen CEO says company 'lost its way,' cuts $125M MS partnership amid declining revenue
3 years ago
R&D
Moderna promises to provide vaccines at no out-of-pocket cost
3 years ago
FDA+
Coronavirus
First page
Previous page
144
145
146
147
148
149
150
Next page
Last page